Samantha Oliver is Joint Managing Director at pH and has responsibility for leading the business development team and managing relationships with our clients, both new and existing. Sam has published widely in the RWE area and has presented on novel methodologies at a number of conferences. This extensive experience allows her to work closely with our clients to develop bespoke solutions to meet their needs.
Sam also provides oversight of a number of projects from their conception to completion acting as the first point of contact for our pharmaceutical industry and NHS partners to ensure their objectives are met throughout the project process.
Sam has a degree in Pharmacology from Manchester University and more than 18 years’ experience in the pharmaceutical industry, gathered in various roles within pharmaceutical, biotech and clinical research organisations. She has a wealth of experience in the Late Phase drug development area, in market preparation and penetration and in effectively using Real World Evidence as a life-cycle management tool